These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 20505082)

  • 1. Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice.
    Heldt SA; Ressler KJ
    J Neurosci; 2010 May; 30(21):7139-51. PubMed ID: 20505082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
    Kralic JE; O'Buckley TK; Khisti RT; Hodge CW; Homanics GE; Morrow AL
    Neuropharmacology; 2002 Sep; 43(4):685-94. PubMed ID: 12367614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype.
    McKernan RM; Rosahl TW; Reynolds DS; Sur C; Wafford KA; Atack JR; Farrar S; Myers J; Cook G; Ferris P; Garrett L; Bristow L; Marshall G; Macaulay A; Brown N; Howell O; Moore KW; Carling RW; Street LJ; Castro JL; Ragan CI; Dawson GR; Whiting PJ
    Nat Neurosci; 2000 Jun; 3(6):587-92. PubMed ID: 10816315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
    Vlainić J; Pericić D
    Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.
    Auta J; Kadriu B; Giusti P; Costa E; Guidotti A
    Pharmacol Biochem Behav; 2010 Jun; 95(4):383-9. PubMed ID: 20227434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazenil: a low efficacy agonist at alpha1- but high efficacy at alpha5-GABAA receptors fail to show anticonvulsant cross tolerance to diazepam or zolpidem.
    Auta J; Impagnatiello F; Kadriu B; Guidotti A; Costa E
    Neuropharmacology; 2008 Aug; 55(2):148-53. PubMed ID: 18555494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential contribution of GABA(A) receptor subtypes to the anticonvulsant efficacy of benzodiazepine site ligands.
    Fradley RL; Guscott MR; Bull S; Hallett DJ; Goodacre SC; Wafford KA; Garrett EM; Newman RJ; O'Meara GF; Whiting PJ; Rosahl TW; Dawson GR; Reynolds DS; Atack JR
    J Psychopharmacol; 2007 Jun; 21(4):384-91. PubMed ID: 17092983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.
    Wright BT; Gluszek CF; Heldt SA
    Psychopharmacology (Berl); 2014 Aug; 231(15):2967-79. PubMed ID: 24531568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pharmacogenetic 'Restriction-of-Function' Approach Reveals Evidence for Anxiolytic-Like Actions Mediated by α5-Containing GABAA Receptors in Mice.
    Behlke LM; Foster RA; Liu J; Benke D; Benham RS; Nathanson AJ; Yee BK; Zeilhofer HU; Engin E; Rudolph U
    Neuropsychopharmacology; 2016 Sep; 41(10):2492-501. PubMed ID: 27067130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voltage-clamp evidence of GABA
    Fernandes H; Batalha V; Braksator E; Hebeisen S; Bonifácio MJ; Vieira-Coelho MA; Soares-da-Silva P
    Pharmacol Rep; 2022 Oct; 74(5):956-968. PubMed ID: 36097257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABAA receptor subtype-selective modulators. I. α2/α3-selective agonists as non-sedating anxiolytics.
    Atack JR
    Curr Top Med Chem; 2011; 11(9):1176-202. PubMed ID: 21050172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of two GABAA receptor benzodiazepine-site ligands that are mediated via non-γ2-dependent modulation.
    Leppä E; Linden AM; Rabe H; Vekovischeva OY; Wulff P; Lüddens H; Wisden W; Korpi ER
    Eur J Pharmacol; 2011 Sep; 666(1-3):111-21. PubMed ID: 21616065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal behavior regulates benzodiazepine/GABAA receptor subunit expression in brain regions associated with fear in BALB/c and C57BL/6 mice.
    Caldji C; Diorio J; Anisman H; Meaney MJ
    Neuropsychopharmacology; 2004 Jul; 29(7):1344-52. PubMed ID: 15085086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes.
    Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H
    Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociating anxiolytic and sedative effects of GABAAergic drugs using temperature and locomotor responses to acute stress.
    Vinkers CH; Klanker M; Groenink L; Korte SM; Cook JM; Van Linn ML; Hopkins SC; Olivier B
    Psychopharmacology (Berl); 2009 Jun; 204(2):299-311. PubMed ID: 19169673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatment.
    Vinkers CH; van Oorschot R; Nielsen EØ; Cook JM; Hansen HH; Groenink L; Olivier B; Mirza NR
    PLoS One; 2012; 7(8):e43054. PubMed ID: 22912786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of the hypnotic zolpidem in vivo.
    Crestani F; Martin JR; Möhler H; Rudolph U
    Br J Pharmacol; 2000 Dec; 131(7):1251-4. PubMed ID: 11090095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.